MARKSANS PHARMA
|
The Current P/E Ratio of MARKSANS PHARMA is 30.36.
Share Price | ₹232.8 | Jan 27,2025 |
Market Cap | ₹10,548.2 Cr | |
Earnings-TTM | ₹347.4 Cr | TTM-Consolidated Results |
Price/Earnings | 30.36x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MARKSANS PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹10,548.2 Cr] as on Jan 27,2025
(/) Earnings [ ₹347.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 30.36x ]
Thus, for MARKSANS PHARMA , the investors are currently willing to pay 30.36 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MARKSANS PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MARKSANS PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of MARKSANS PHARMA
PE Ratio Performance Analysis for MARKSANS PHARMA
- MARKSANS PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.50x.
- MARKSANS PHARMA 's operated at median p/e ratio of 10.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MARKSANS PHARMA 's p/e ratio peaked in Mar2024 at 21.89x.
- MARKSANS PHARMA 's p/e ratio hit its five-year low in Mar2020 of 4.86x.
How does MARKSANS PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MARKSANS PHARMA | 347.44 | 30.36 | 10,548.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.47 | 428,461.0 |
CIPLA LTD | 4,485.22 | 25.13 | 112,735.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.41 | 99,913.9 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 21.59 | 92,815.0 |
DIVIS LABORATORIES LTD | 1,836.00 | 80.60 | 147,983.0 |
MANKIND PHARMA LTD | 2,050.73 | 49.48 | 101,461.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 60.63 | 112,895.0 |
LUPIN LTD | 2,651.94 | 35.76 | 94,823.8 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.97 | 68,261.6 |
ABBOTT INDIA LTD | 1,284.66 | 43.89 | 56,379.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MARKSANS PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.41x |
Max industry PE | 80.60x |
Median industry PE | 35.76x |
Average industry PE | 38.48x |
You may also like the below Video Courses